Atypical fibroxanthoma-like amelanotic malignant melanoma: A case report and literature review  by Hsu, Chao-Kai et al.
at SciVerse ScienceDirect
DERMATOLOGICA SINICA 31 (2013) 140e144Contents lists availableDermatologica Sinica
journal homepage: http: / /www.derm-sinica.comCASE REPORT
Atypical ﬁbroxanthoma-like amelanotic malignant melanoma:
A case report and literature review
Chao-Kai Hsu 1,2, Sheau-Chiou Chao 1, Shyh-Jou Shieh 3, Julia Yu-Yun Lee 1,*
1Department of Dermatology, National Cheng Kung University, College of Medicine and Hospital, Tainan, Taiwan
2 Institute of Clinical Medicine, National Cheng Kung University, College of Medicine and Hospital, Tainan, Taiwan
3Department of Surgery, National Cheng Kung University, College of Medicine and Hospital, Tainan, Taiwana r t i c l e i n f o
Article history:
Received: Feb 18, 2012
Revised: Aug 26, 2012
Accepted: Sep 26, 2012
Keywords:
atypical ﬁbroxanthoma
CD68
melanoma* Corresponding author. Department of Dermato
University, College of Medicine and Hospital, 138 Sh
Tel.: þ886 6 2353535x5419; fax: þ886 6 2374196.
E-mail address: yylee@mail.ncku.edu.tw (J.Y.-Y. Le
1027-8117/$ e see front matter Copyright  2012, Ta
http://dx.doi.org/10.1016/j.dsi.2012.09.007a b s t r a c t
Atypical ﬁbroxanthoma (AFX)-like malignant melanoma is very rare. Here, we report a case of ame-
lanotic AFX-like melanoma in a 72-year-old Taiwanese woman presenting with two separate,
asymptomatic, enlarging erythematous nodules within a large hypopigmented patch on her left cheek.
Histologically, both lesions showed cellular nodules in the reticular dermis separated from the over-
lying ﬂattened epidermis by a zone of solar elastosis or ﬁbrosis. The tumor consisted of sheets of
atypical epithelioid cells arranged in a vague nesting pattern, as well as many atypical large or gigantic
cells with one or more, large hyperchromatic, vesicular, or pleomorphic nuclei with prominent
nucleoli, and moderate-to-abundant eosinophilic or foamy cytoplasm. Focal intraepidermal prolifera-
tion of atypical melanocytes with a pagetoid pattern was found only in the periphery of the main
tumor. The tumor cells were moderately to strongly positive for S-100, Melan-A, and HMB-45.
The pleomorphic giant cells were focally CD68-positive but CD163-negative. The patient underwent
tumor excision followed by radiotherapy due to the narrow surgical margins. A sentinel lymph node
biopsy revealed no metastasis of the melanoma. This case illustrates the importance of scrutinizing any
subtle proliferation of atypical melanocytes in the epidermis in an AFX-like tumor in order to avoid
misdiagnosis.
Copyright  2012, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Malignant melanoma may simulate various types of soft tissue
tumor, such as dermatoﬁbrosarcoma protuberans, malignant
ﬁbrous histiocytoma (MFH), myxoﬁbrosarcoma (myxoid MFH),
malignant hemangiopericytoma, and malignant schwannoma.1
Malignant melanoma mimicking atypical ﬁbroxanthoma (AFX)
appears to be very rare, only four reported cases being found in
a Medline search.1e3
Here, we report a case of AFX-like malignant melanoma pre-
senting with two asymptomatic, enlarging nodules on the cheek of
an elderly female. After tumor excision and postoperative radio-
therapy, there was no recurrence of the tumor during a 16-month
follow-up.logy, National Cheng Kung
eng-Li Road, Tainan, Taiwan.
e).
iwanese Dermatological AssociatioCase report
A 72-year-old Taiwanese woman presented with a 2-year history of
two asymptomatic, enlarging nodules on her left cheek. Examina-
tion revealed two erythematous, dome-shaped nodules measuring
0.9  0.6 cm and 0.6  0.5 cm, respectively, within a large hypo-
pigmented patch (Figure 1). Biopsy specimens of both lesions
showed well-circumscribed cellular nodules in the reticular dermis
separated from the overlying ﬂattened epidermis by a zone of solar
elastotic or ﬁbrotic upper dermis (Figure 2A).
The nodules consisted primarily of sheets of atypical epithelioid
cells arranged in vague nesting pattern (Figure 2B), as well as giant
or gigantic cells with two or more large pleomorphic nuclei
(Figure 2C). Both types of atypical cell had large hyperchromatic,
and one or more vesicular, nuclei, mostly with a prominent
nucleolus, and moderate-to-abundant eosinophilic cytoplasm.
Some giant cells also had foamy cytoplasm in places (Figure 2C).
In addition to these two major types of cell, there were also
atypical, oval or spindled cells in some foci. Increased mitotic ratesn. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 A 72-year-old Taiwanese woman presents with two enlarging asymptomatic
erythematous nodules, measuring 0.9  0.6 cm and 0.6  0.5 cm, respectively, over
a large hypopigmented patch on her left cheek that had been present for 2 years.
Figure 2 (A) Histology of the lower nodule on the cheek revealed a well-circumscribed, cel
consists of sheets of atypical epithelioid cells with large hyperchromatic nuclei (H&E stain,
foamy or eosinophilic cytoplasm (inset) (H&E stain, 400).
C.-K. Hsu et al. / Dermatologica Sinica 31 (2013) 140e144 141with atypical mitotic features were present. A patchy dense
inﬂammatory inﬁltrate, mostly of small lymphocytes, was found at
the periphery of the tumors. One of the tumors also showed
lymphoid follicles. There was no vascular or perineural invasion, or
obvious inﬁltration of melanophages. The morphology of the
dermal tumors resembled AFX.
However, close inspection revealed some atypical melanocytes
in the epidermis with pagetoid spread in one small focus away from
the dermal nodules (Figure 3). Fontana-Masson staining revealed
an absence of melanin in the tumor nodules and reduced
pigmentation in the overlying epidermis. The tumor cells showed
a moderate-to-strong expression of S-100, Melan-A, and HMB-45
(Figure 4). The pleomorphic giant cells were focally CD68-positive
but CD163-negative (not shown). Based on the pathological ﬁnd-
ings, AFX-like amelanotic malignant melanoma, with a Breslow
thickness of 3.4 mm and a Clark level of IV, was diagnosed.
Positron emission tomography revealed hypermetabolic
changes in the tumors on the cheek without evidence of distant
metastasis. The tumor was excised with a sentinel lymph node
biopsy, the latter being negative for metastasis. Because of the
narrow surgical margin (less than 1 mm), the patient underwent
postoperative radiotherapy. During a 16-month follow-up, there
was no evidence of recurrence either clinically on or imaging study.Discussion
We have described here a rare case of AFX-like malignant mela-
noma manifesting as two amelanotic nodules on the cheek of an
elderly Taiwanese woman. Interestingly, both nodules were located
within a large hypopigmented patch, a ﬁnding suggestive of the
halo phenomenon. Malignant melanoma may have a wide variety
of clinicopathological presentations,1 but the AFX-like variant is
very rare.1e3 Four cases of this variant have been reported, and their
ﬁndings are summarized in Table 1.1e3lular tumor in the reticular dermis (H&E stain, scanning magniﬁcation). (B) The nodule
40). (C) Many giant or gigantic cells have two or more huge, pleomorphic nuclei and
Figure 3 Focal proliferation of atypical melanocytes, mostly as solitary units, in the lower epidermis, can be found only in small foci in the epidermis away from the dermal nodule
(H&E stain, 20). Some atypical melanocytes have multiple nuclei and abundant, eosinophilic or pale cytoplasm (inset; H&E stain, 200).
C.-K. Hsu et al. / Dermatologica Sinica 31 (2013) 140e144142AFX is a tumor that was ﬁrst described by Helwig in the
1960s and is believed to be of ﬁbrohisiocytic origin.4 Most AFX
tumors display a rapidly growing, ulcerated or bleeding nodule
on the sun-damaged skin of an elderly person.4 Although AFX
has the capacity for local recurrence or even metastasis, it is
usually cured by complete excision.5 AFX-like melanoma,
however, has a much worse prognosis. In the three cases of AFX-
like melanoma described by Sangueza and Zelger (Table 1), all
the lesions were found on the faces of elderly patients, and the
diagnosis was delayed due to the unusual clinicopathological
presentations. Two of three patients died due to rapid recur-
rence or metastasis.2Figure 4 (A, B) Immunohistochemical staining reveals that atypical epithelioid cells and gian
cells are strongly S-100 protein-positive, but the giant cells are mostly S-100 protein-negatPrevious reports have highlighted the difﬁculties in dis-
tinguishing malignant melanoma from AFX, and the use of
immunohistochemistry is often necessary.6,7 Characteristic
markers of melanomas such as S-100 protein, Melan-A/MART1, and
HMB45 are not expressed in classic AFX. However, melanomas may
rarely be S100-protein negative, and not uncommonly Melan-A/
MART1-, HMB45-, and/or NKIC3-negative.8,9 In one AFX-like
melanoma reported by Sangueza and Zelger, the diagnosis was
delayed due to the negative results for S-100, Melan-A, and HMB45
in the ﬁrst excisional specimen.2
CD68 expression is variable in AFX and MFH, so is not very
useful for distinguishing these tumors from spindle cellt cells are moderately to strongly positive for Melan-A and HMB-45. (C) The epithelioid
ive. (D) A few pleomorphic giant cells are focally CD68-positive (200).
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C.-K. Hsu et al. / Dermatologica Sinica 31 (2013) 140e144 143melanomas.10,11 Smith-Zagone et al showed that the tumor cells of
AFX were diffusely CD68-positive, and HMB-45 and Melan-A/
MART1 expression was only limited to the large, multinucleated
cells with vacuolated cytoplasm.6
In our case, the epithelioid tumor cells showed moderate-to-
strong positivity for S-100, Melan-A, and HMB-45, while the giant
or gigantic cells were mostly S-100-negative but Melan-A- and
HMB-45-positive. Although some gigantic cells were CD68-
positive, they were negative for CD163, a more speciﬁc marker
for histiocytes.12
Other differential diagnoses of AFX-like melanoma include MFH
and a rare example of Merkel cell carcinoma with AFX-like
features.13,14 The tumor cells in MFH were mostly S-100- and
HMB-45-negative, although two cases of S-100-positive MFH have
been reported.15 Merkel cell carcinoma, recently found to be
associated with clonal integration of the Merkel cell polyomavirus,
is usually neuron-speciﬁc enolase-positive and shows character-
istic paranuclear dot-like positivity for monokeratin.14,16
It may be difﬁcult to differentiate epidermotropic metastatic
melanoma from primary melanoma, and the importance of dis-
tinguishing a local persistence of primary lesions from metastatic
lesions has been re-emphasized.17 With our patient, although the
possibility of a metastatic melanoma could not be completely
excluded histologically, the ﬁnding of an intraepidermal prolifera-
tion of atypical melanocytes off to one side of the dermal tumor in
conjunction with an absence of dermal scarring favored the diag-
nosis of primarymelanoma. This was further supported by negative
ﬁndings from the positron emission tomography examination and
sentinel lymph node biopsy. The two lesions may represent
a primary amelanotic melanoma and a satellite metastasis. The
tumor was N2c according to the staging system of the American
Joint Committee on Cancer, and should be treated as having nodal
metastases.18,19
In addition to AFX-like malignant melanoma, collision tumors of
AFX and invasive melanoma have also been reported.20,21 Wilsher
reported a 76-year-old male who presented with a 17 mm ulcerated
noduleonhis scalp.20Similarly,McGregoret al. reporteda71-year-old
male with a 0.6 cm pearly papule on his back.21 With immunohisto-
chemical staining, both cases were conﬁrmed to contain two distinct
but contiguous neoplastic components of AFX and melanoma.
In sum, we have described here a rare case of AFX-like amela-
notic malignant melanoma, which may be the ﬁfth such case re-
ported. This melanoma appeared to be a primary one and
manifested as two discrete amelanotic nodules in association with
a halo-like phenomenon. Our case illustrates the importance of
scrutinizing any subtle proliferation of atypical melanocytes in the
epidermis in an AFX-like tumor in order to avoid misdiagnosis.References
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